Filing Details

Accession Number:
0001140361-14-037656
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-08 16:18:49
Reporting Period:
2014-10-08
Filing Date:
2014-10-08
Accepted Time:
2014-10-08 16:18:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1557883 Dermira Inc. DERM Pharmaceutical Preparations (2834) 273267680
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1419148 Canaan Viii Lp 285 Riverside Ave
Ste 250
Westport CT 06880
Yes No Yes No
1552200 Canaan Partners Viii Llc 285 Riverside Ave
Ste 250
Westport CT 06880
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-08 2,450,873 $0.00 2,450,873 No 4 C Direct
Common Stock Acquisiton 2014-10-08 49,276 $16.00 2,500,149 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2014-10-08 1,708,040 $0.00 1,708,040 $0.00
Common Stock Series B Preferred Stock Disposition 2014-10-08 469,878 $0.00 469,878 $0.00
Common Stock Series C Preferred Stock Disposition 2014-10-08 272,955 $0.00 272,955 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. In connection with the consummation of the Issuer's initial public offering on October 8, 2014, each share of Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration. All shares of Common Stock issued upon conversion were aggregated.
  2. Shares held directly by Canaan VIII L.P. (the "Canaan Fund"). Canaan Partners VIII LLC ("Canaan VIII" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Wende Hutton, a manager and member of Canaan VIII, serves as the representative of the Canaan Entities on the Issuer's board of directors. Investment and voting decisions with respect to the shares held by the Canaan Fund are made by the managers of Canaan VIII, collectively, and no manager of Canaan VIII has beneficial ownership of any shares held by Canaan VIII L.P.
  3. None.